Parkside Investments’s Zimmer Biomet ZBH Stock Holding History

Parkside Investments’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-4,635	Closed	-$591K	–	171
2018 Q3	$591K	Buy	+4,635	New	+$551K	0.28%	64

Other funds holding ZBH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Parkside Investments's ZBH Position: Q4 2018 in Review

Parkside Investments sold out of Zimmer Biomet (ZBH) in Q4 2018, closing a stake of 4,635 shares — an estimated $591K sold.

Parkside Investments first reported a position in ZBH in Q3 2018 and held it in 1 quarter. The position peaked at $591K in Q3 2018. 872 funds tracked by Wall St. Rank hold ZBH as of Q4 2018.

Parkside Investments reported no remaining Zimmer Biomet position as of Q4 2018 after selling out during the quarter.
Parkside Investments sold 4,635 Zimmer Biomet shares in Q4 2018, an estimated $591K.
Parkside Investments first reported a position in Zimmer Biomet in Q3 2018 and held it in 1 quarter.
Parkside Investments's Zimmer Biomet position peaked at $591K in Q3 2018.
872 funds tracked by Wall St. Rank held Zimmer Biomet as of Q4 2018.

Based on Parkside Investments's 13F filing for Q4 2018, filed 4 Feb 2019.